The Latest in ALL

FDA approves new ALL treatment for children, young adults

January 7, 2019

ALL

ALL chemotherapy looks effective in mixed phenotype leukemia

January 3, 2019

FDA expands dasatinib indication to children with Ph+ ALL

January 3, 2019

ALL

FDA approves Elzonris for blastic plasmacytoid dendritic cell neoplasm

December 21, 2018

ALL

ELIANA update: Tisagenlecleucel responses durable in r/r B-cell ALL

December 2, 2018

Stem cell transplant after CAR T cells may reduce B-ALL relapse risk

December 1, 2018

Prognostic features could improve ALL outcomes

November 13, 2018

ALL

Report details financial burden of blood cancers

November 8, 2018

Kymriah appears cost effective in analysis

October 17, 2018

Researchers consider R/R ALL drugs in the first-line setting

October 17, 2018

ALL

First reported case of induced resistance to tisagenlecleucel

October 1, 2018

FDA authorizes ClonoSEQ to detect MRD in ALL, myeloma

September 29, 2018

FDA grants OBI-3424 orphan designation for ALL

September 24, 2018

ALL

Bacteremic sepsis in ALL linked to later cognitive issues

September 24, 2018

Researchers propose new acute leukemia subtypes

September 18, 2018